Centrally necrotizing carcinoma of the breast: Clinicopathological analysis of 33 cases indicating its basal-like phenotype and poor prognosis

Histopathology

Volumn 57, Issue 2, 2010, Pages 193-201

  Yu, Lin ^a   Yang, Wentao ^a   Cai, Xu ^a   Shi, Daren ^a   Fan, Yuezhen ^a   Lu, Hongfen ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

basal like immunophenotype; breast carcinoma; central necrosis; prognosis

Indexed keywords

CYTOKERATIN 14; CYTOKERATIN 17; CYTOKERATIN 18; CYTOKERATIN 5; CYTOKERATIN 6; CYTOKERATIN 8; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN P63; SMOOTH MUSCLE ACTIN; VIMENTIN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST FIBROSIS; BREAST NECROSIS; CANCER GRADING; CANCER MORPHOLOGY; CANCER RECURRENCE; CENTRALLY NECROTIZING CARCINOMA OF THE BREAST; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INFARCTION; MASTECTOMY; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; SCAR; TUMOR CELL;

ACTINS; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MIDDLE AGED; NECROSIS; NEOPLASMS, HORMONE-DEPENDENT; PHENOTYPE; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS; VIMENTIN;

EID: 77955818999     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2010.03601.x     Document Type: Article

References (16)

1. Tsuda H, Takarabe T, Hasegawa T et al. Myoepithelial differentiation in high-grade invasive ductal carcinomas with large central acellular zones. Hum. Pathol. 1999 30 1134 1139.
2. Tsuda H, Takarabe T, Hasegawa F et al. Large, central acellular zones indicating myoepithelial tumor differentiation in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases. Am. J. Surg. Pathol. 2000 24 197 202.
3. Jimenez RE, Wallis T, Visscher DW. Centrally necrotizing carcinomas of the breast: a distinctive histologic subtype with aggressive clinical behavior. Am. J. Surg. Pathol. 2001 25 331 337.
4. Elston EW, Ellis IO. Method for grading breast cancer. J. Clin. Pathol. 1993 46 189 190.
5. Carey LA, Perou CM, Livasy CA et al. Race, breast cancer subtypes, and survival in the Carolina breast cancer study. JAMA 2006 295 2492 2502.
6. Hasebe T, Tsuda H, Tsubono Y et al. Fibrotic focus in invasive ductal carcinoma of the breast: a histopathological prognostic parameter for tumor recurrence and tumor death within three years after the initial operation. Jpn. J. Cancer Res. 1997 88 590 599.
7. Hamperl H. The myoepithelia (myoepithelial cells): normal state; regressive changes; hyperplasia; tumors. Curr. Top. Pathol. 1970 53 1612 1620.
8. Allen AC. So-called mixed rumors of the mammary gland of dog and man, with special reference to the general problem of cartilage and bone formation. Arch. Pathol. 1940 29 589 624.
9. Fulford LG, Easton DF, Reis-Filho JS et al. Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast. Histopathology 2006 49 22 34.
10. Fadare O, Tavassoli FA. The phenotypic spectrum of basal-like breast cancers: a critical appraisal. Adv. Anat. Pathol. 2007 14 358 373.
11. Livasy CA, Karaca G, Nanda R et al. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod. Pathol. 2006 19 264 271.
12. Laakso M, Loman N, Borg A et al. Cytokeratin 514-positive breast cancer: true basal phenotype confined to BRCA1 tumors. Mod. Pathol. 2005 18 1321 1328.
13. Kim MJ, Ro JY, Ahn SH et al. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2neu-overexpressing phenotypes. Hum. Pathol. 2006 37 1217 1226.
14. Liu H, Fan QH, Zhang ZH et al. Basal-HER2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers. Hum. Pathol. 2008 39 167 174.
15. Carter D, Pipkin RD, Shepard RH et al. Relationship of necrosis and tumor border to lymph node metastases and 10-year survival in carcinoma of the breast. Am. J. Surg. Pathol. 1978 2 39 46.
16. Gilchrist KW, Gray R, Fowble B et al. Tumor necrosis is a prognostic predictor for early recurrence and death in lymph node positive breast cancer: a 10-year follow-up study of 728 Eastern Cooperative Oncology Group patients. J. Clin. Oncol. 1993 11 1929 1935.